The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts
Experts in Chronic Myeloid Leukemia, Camille Abboud, Ellin Berman, Adam Cohen, Jorge Cortes, Daniel DeAngelo, Michael Deininger, Steven Devine, Brian Druker, Amir Fathi, Elias Jabbour, Madan Jagasia, Hagop Kantarjian, Jean Khoury, Pierre Laneuville, Richard Larson, Jeffrey Lipton, Joseph O Moore, Tariq Mughal, Susan O'Brien, Javier Pinilla-Ibarz, Alfonso Quintas-Cardama, Jerald Radich, Vishnu Reddy, Charles Schiffer, Neil Shah, Paul Shami, Richard T Silver, David Snyder, Richard Stone, Moshe Talpaz, Ayalew Tefferi, Richard A Van Etten, Meir Wetzler, Elisabetta Abruzzese, Jane Apperley, Massimo Breccia, Jenny Byrne, Francisco Cervantes, Ekaterina Chelysheva, R E Clark, Hugues de Lavallade, Iryna Dyagil, Carlo Gambacorti-Passerini, John Goldman, Ibrahim Haznedaroglu, Henrik Hjorth-Hansen, Tessa Holyoake, Brian Huntly, Philipp le Coutre, Elza Lomaia, Francois-Xavier Mahon, David Marin-Costa, Giovanni Martinelli, Jiri Mayer, Dragana Milojkovic, Eduardo Olavarria, Kimmo Porkka, Johan Richter, Philippe Rousselot, Giuseppe Saglio, Guray Saydam, Jesper Stentoft, Anna Turkina, Paolo Vigneri, Andrey Zaritskey, Alvaro Aguayo, Manuel Ayala, Israel Bendit, Raquel Maria Bengio, Carlos Best, Eduardo Bullorsky, Eduardo Cervera, Carmino DeSouza, Ernesto Fanilla, David Gomez-Almaguer, Nelson Hamerschlak, Jose Lopez, Alicia Magarinos, Luis Meillon, Jorge Milone, Beatriz Moiraghi, Ricardo Pasquini, Carolina Pavlovsky, Guillermo J Ruiz-Arguelles, Nelson Spector, Christopher Arthur, Peter Browett, Andrew Grigg, Jianda Hu, Xiao-jun Huang, Tim Hughes, Qian Jiang, Saengsuree Jootar, Dong-Wook Kim, Hemant Malhotra, Pankaj Malhotra, Itaru Matsumura, Junia Melo, Kazunori Ohnishi, Ryuzo Ohno, Tapan Saikia, Anthony P Schwarer, Naoto Takahashi, Constantine Tam, Tetsuzo Tauchi, Kensuke Usuki, Jianxiang Wang, Fawzi Abdel-Rahman, Mahmoud Deeb Saeed Aljurf, Ali Bazarbachi, Dina Ben Yehuda, Naeem Chaudhri, Muheez Durosinmi, Hossam Kamel, Vernon Louw, Bassam Francis Matti, Arnon Nagler, Pia Raanani, Ziad Salem, Experts in Chronic Myeloid Leukemia, Camille Abboud, Ellin Berman, Adam Cohen, Jorge Cortes, Daniel DeAngelo, Michael Deininger, Steven Devine, Brian Druker, Amir Fathi, Elias Jabbour, Madan Jagasia, Hagop Kantarjian, Jean Khoury, Pierre Laneuville, Richard Larson, Jeffrey Lipton, Joseph O Moore, Tariq Mughal, Susan O'Brien, Javier Pinilla-Ibarz, Alfonso Quintas-Cardama, Jerald Radich, Vishnu Reddy, Charles Schiffer, Neil Shah, Paul Shami, Richard T Silver, David Snyder, Richard Stone, Moshe Talpaz, Ayalew Tefferi, Richard A Van Etten, Meir Wetzler, Elisabetta Abruzzese, Jane Apperley, Massimo Breccia, Jenny Byrne, Francisco Cervantes, Ekaterina Chelysheva, R E Clark, Hugues de Lavallade, Iryna Dyagil, Carlo Gambacorti-Passerini, John Goldman, Ibrahim Haznedaroglu, Henrik Hjorth-Hansen, Tessa Holyoake, Brian Huntly, Philipp le Coutre, Elza Lomaia, Francois-Xavier Mahon, David Marin-Costa, Giovanni Martinelli, Jiri Mayer, Dragana Milojkovic, Eduardo Olavarria, Kimmo Porkka, Johan Richter, Philippe Rousselot, Giuseppe Saglio, Guray Saydam, Jesper Stentoft, Anna Turkina, Paolo Vigneri, Andrey Zaritskey, Alvaro Aguayo, Manuel Ayala, Israel Bendit, Raquel Maria Bengio, Carlos Best, Eduardo Bullorsky, Eduardo Cervera, Carmino DeSouza, Ernesto Fanilla, David Gomez-Almaguer, Nelson Hamerschlak, Jose Lopez, Alicia Magarinos, Luis Meillon, Jorge Milone, Beatriz Moiraghi, Ricardo Pasquini, Carolina Pavlovsky, Guillermo J Ruiz-Arguelles, Nelson Spector, Christopher Arthur, Peter Browett, Andrew Grigg, Jianda Hu, Xiao-jun Huang, Tim Hughes, Qian Jiang, Saengsuree Jootar, Dong-Wook Kim, Hemant Malhotra, Pankaj Malhotra, Itaru Matsumura, Junia Melo, Kazunori Ohnishi, Ryuzo Ohno, Tapan Saikia, Anthony P Schwarer, Naoto Takahashi, Constantine Tam, Tetsuzo Tauchi, Kensuke Usuki, Jianxiang Wang, Fawzi Abdel-Rahman, Mahmoud Deeb Saeed Aljurf, Ali Bazarbachi, Dina Ben Yehuda, Naeem Chaudhri, Muheez Durosinmi, Hossam Kamel, Vernon Louw, Bassam Francis Matti, Arnon Nagler, Pia Raanani, Ziad Salem
Abstract
As a group of more than 100 experts in chronic myeloid leukemia (CML), we draw attention to the high prices of cancer drugs, with the particular focus on the prices of approved tyrosine kinase inhibitors for the treatment of CML. This editorial addresses the multiple factors involved in cancer drug pricing and their impact on individual patients and health care policies, and argues for the need to (1) lower the prices of cancer drugs to allow more patients to afford them and (2) maintain sound long-term health care policies.
Source: PubMed